Coya Therapeutics, Inc. (COYA), a company focused to enhance regulatory T cell function, said on Monday that it has promoted its Chief Business Officer, Arun Swaminathan, as Chief Executive Officer with effect from November 1.
He will succeed, Howard Berman, who will continue to serve in the capacity of Executive Chair.
Prior to joining Coya as its Chief Business Officer, a role he has served in since April 2023, he had executed significant commercial transactions at Alteogen Inc. and Actinium Pharmaceuticals.
Swaminathan was also the founder and CEO of Lynkogen, Inc., a company developing GLP-1 fusion proteins.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.